Ascendis will lead early development of the product candidates, while Novo will be responsible for the costs
BMI, waist circumference, and waist-to-height ratio improved significantly with combination therapy
A Risky Dynamic When two companies dominate an entire drug category, market concentration creates both opportunity and vulnerability
It simply means week one is a good time to keep meals soft, simple, and low-grease
If your BMI is just under the threshold, the addition of HRT for documented hormonal deficiency may support your case for GLP-1 prescription
This may involve: A healthcare professional will normally guide the transition to ensure treatment remains safe and effective Wegovy and Ozempic contain the same active ingredient, semaglutide, but they are approved for different uses and are prescribed at different doses